How Private Equity Is Buying Up Dermatology Practices

Private equity has been quietly consolidating dermatology for years, but the pace has accelerated dramatically. In this episode, Lucas and Luna examine the roll-up strategy behind U.S. Dermatology Partners, one of the largest PE-backed dermatology platforms, and break down the economics: why dermatology offers recession-resistant recurring revenue, high margins, and a fragmented market of 11,000 independent practices. They discuss the role of mid-level providers, the tension with referring physicians, and whether patients actually benefit. Specific numbers include the 40 percent EBITDA margins typical of mature dermatology clinics and the 8 to 12 times EBITDA multiples PE firms are paying. If you've ever wondered why your dermatologist suddenly has a new logo on the door, this episode explains what's happening behind the scenes. #PrivateEquity #Dermatology #RollUps #HealthcareInvesting #USDermatologyPartners #PEBackedPlatforms #FragmentedMarkets #Consolidation #EBITDA #MidLevelProviders #PhysicianPracticeManagement #RecessionResilient #BusinessAcquisitions #TheBuyoutShow #FexingoBusiness #BusinessPodcast #HealthcareConsolidation #DermatologyPractice Keep every episode free: buymeacoffee.com/fexingo